Schizophrenia Trial, Recruiting NCT04730518 Sponsor: Charite University, Berlin, Germany Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT04730518
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You can be male or female
  • You are currently receiving care as an inpatient on a psychiatric ward for psychosis, or attending a day clinic for social and psychiatric support
  • You are 18 years old or older
  • You have been diagnosed with a schizophrenia-spectrum disorder (a group of conditions related to schizophrenia), confirmed using standard medical guidelines
  • You are able to understand the study and agree to take part
  • You are willing and able to take part in group therapy sessions
  • Your current psychotic symptoms are at a low to moderate level, as measured by a standard clinical assessment tool (confirm with trial site)

Who may not be able to join:

  • Your psychotic symptoms are currently severe, as shown by a high score on a standard clinical assessment (confirm with trial site)
  • You are currently experiencing serious thoughts of suicide, as measured by a standard assessment tool (confirm with trial site)
  • You have a neurological condition (a disorder affecting the brain or nervous system) that may affect your thinking or memory
  • You are currently misusing alcohol or drugs, not including nicotine or medications prescribed to you by a doctor
  • You are currently receiving certain other treatments at the same time, such as electroconvulsive therapy (ECT) or ketamine treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0049 30 450 517 789

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 January 2021
Est. completion
30 July 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

PANSS Symptomatology - Positive and Negative Symptoms; Proportion of pp receiving threshold dose (Acceptability); Nr. of pp willing to participate in YoGI (Operational Feasibility)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov